Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Summary

Brief summary (as posted)

Clinical data are being used to build a mathematical model to describe the clinical results of radiotherapy for prostate cancer.

Conditions

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Prostate Cancer	Malignant Prostate Neoplasm	CURATED_EXACT	0.92

Interventions

Data not yet available

No intervention recorded.

Eligibility

Show eligibility criteria text

Inclusion Criteria:

* Prostate cancer treated with radiotherapy +/- hormones

Exclusion Criteria:

* Prostatectomy

References

Data not yet available

No reference posted for this study.

Registry

Start: Feb 1, 2004
Primary completion: Mar 1, 2008
Completion: Apr 1, 2008
First posted: Aug 5, 2005
Last update posted: Feb 24, 2016
Enrollment: 1,000 (actual)
Lead sponsor: AHS Cancer Control Alberta OTHER
Collaborators: Cross Cancer Institute
Keywords: prostate cancer, prostate specific antigen, radiotherapy, mathematical modeling

Data updated 22 days agoSource updated Feb 24, 2016source: clinicaltrials

Locations

Country	Sites	Recruiting
Canada	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.